XFOR Buybacks
4 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–4; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| X4 Pharmaceuticals, Inc | 2023-03-31 | Reported repurchase cash | $443,000.00 |
| X4 Pharmaceuticals, Inc | 2022-12-31 | Reported repurchase cash | $0.00 |
| X4 Pharmaceuticals, Inc | 2021-12-31 | Reported repurchase cash | $0.00 |
| X4 Pharmaceuticals, Inc | 2020-12-31 | Reported repurchase cash | $0.00 |